英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
intter查看　intter　在百度字典中的解释百度英翻中〔查看〕
intter查看　intter　在Google字典中的解释Google英翻中〔查看〕
intter查看　intter　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • NATPARA® (parathyroid hormone) for Hypoparathyroidism
    NATPARA is a prescription parathyroid hormone used with calcium and vitamin D to control low blood calcium (hypocalcemia) in people with low parathyroid hormone blood levels (hypoparathyroidism) It is only for people who do not respond well to treatment with calcium and active forms of vitamin D alone, because it may increase the possible risk of bone cancer (osteosarcoma)
  • Takeda to Discontinue Manufacturing of NATPAR® NATPARA® for Patients . . .
    Takeda has great empathy for hypoparathyroidism patients who rely on NATPAR NATPARA and deeply regrets that we could not resolve these issues Takeda is communicating this information now following consultation and alignment with regulatory authorities and to allow time for patients to consult with their healthcare teams to develop longer-term
  • PTH Replacement Therapies: Current Options and What’s Ahead
    The table below summarizes the three key therapies—Natpara, Forteo, and YORVIPATH—with attention to their origin, approval status, and role in clinical practice Comparison of PTH Replacement Therapies for Hypoparathyroidism Understanding Each Option Natpara was the first therapy FDA-approved specifically for hypoparathyroidism
  • NATPARA® (nat-PAH-rah) (parathyroid hormone) for injection What is the . . .
    What is NATPARA? • NATPARA is a prescription parathyroid hormone (PTH) used with calcium and vitamin D to control low blood calcium (hypocalcemia) in people with low PTH blood levels (hypoparathyroidism) ment with calcium and active forms of vitamin D alone, because it may increase the possible risk of bone ca
  • Natpara: Side Effects, Dosage Uses - Drugs. com
    Natpara (parathyroid hormone) is used to treat hypocalcemia in patients with hypoparathyroidism Includes Natpara alternatives, side effects, interactions, and indications
  • PTH(1-84) replacement therapy for the treatment of hypoparathyroidism
    PTH (1-84) replacement therapy for hypoparathyroidism is promising, although further acquisition of long-term data is needed Keywords: hypoparathyroidism, natpara, parathyroid, parathyroid hormone, PTH (1-84) Parathyroid hormone (PTH) is critically important for the control of calcium and phosphate homeostasis
  • FAQs About Natpara for Hypoparathyroidism
    Natpara is marketed by Takeda Pharmaceuticals, and was developed by Shire, now part of Takeda How does Natpara work? Hypoparathyroidism results from low levels of parathyroid hormone (PTH), produced in the four parathyroid glands of the neck PTH deficiency leads to low blood levels of calcium ions (hypocalcemia) and high blood levels of
  • Managing Hypoparathyroidism | NATPARA® (parathyroid hormone)
    NATPARA works by treating low blood calcium in hypoparathyroidism NATPARA is the first and only FDA-approved prescription parathyroid hormone that is taken along with calcium and vitamin D to control hypocalcemia in adults with hypoparathyroidism
  • Takeda to Stop Natpara Production for Hypoparathyroidism
    In 2019, Takeda Pharmaceutical Company experienced some manufacturing and production issues related to its product Natpara, a treatment option for individuals with hypoparathyroidism The product was recalled in the United States due to a potential issue related to rubber particulates from the cartridge’s rubber septum
  • Recombinant Human Parathyroid Hormone (1-84): A Review in . . .
    Abstract Full-length recombinant human parathyroid hormone [rhPTH (1-84); Natpara (®)] is approved in the USA as an adjunct to calcium and vitamin D therapy for control of hypocalcaemia in patients with hypoparathyroidism This article reviews the clinical efficacy and tolerability of rhPTH (1-84) in hypoparathyroidism and summarizes its pharmacological properties In a pivotal phase III





中文字典-英文字典  2005-2009